Pregled bibliografske jedinice broj: 6742
Prognosis in monoclonal gammopathy of undetermined significance
Prognosis in monoclonal gammopathy of undetermined significance // British journal of haematology, 97 (1997), 3; 649-651 (podatak o recenziji nije dostupan, članak, ostalo)
CROSBI ID: 6742 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prognosis in monoclonal gammopathy of undetermined significance
Autori
Vučković, Joško ; Ilić, Anita ; Knežević, Nebojša ; Marinković, Marija ; Zemunik, Tatijana ; Dubravčić, Mirko
Izvornik
British journal of haematology (0007-1048) 97
(1997), 3;
649-651
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
monoclonal gammopathy of undetermined significance; prognosis; malignant transformation
Sažetak
Eighty-seven patients with monoclonal gammopathy of undetermined significance (MGUS) were followed for a period of 1-20 years, median 91 months. Transformation to multiple myeloma occurred in 14 patients of whom seven died as a consequence of the disease. There were 13 unrelated deaths. The actuarial probability of survival was 80% at 10 years and 44% at 15 years and the probabilities of malignant conversion for the same periods were 17% and 30% respectively. The most significant factor influencing the probability of malignant conversion was the increase of monoclonal protein above the level of 30 g/l during the observation period (P<0.001), followed by an increase of M-protein to more than 50% above the baseline level (P=0.02) and a decreased level of uninvolved immunoglobulins (P=0.054).
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108091
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Mirko Dubravčić
(autor)
Anita Ilić
(autor)
Tatijana Zemunik
(autor)
Marija Marinković
(autor)
Joško Vučković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE